Literature DB >> 19377084

Ectopic expression of CGG containing mRNA is neurotoxic in mammals.

Vera Hashem1, Jocelyn N Galloway, Mayra Mori, Rob Willemsen, Ben A Oostra, Richard Paylor, David L Nelson.   

Abstract

Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) is a progressive neurodegenerative disorder that has been diagnosed in a substantial fraction of older male fragile X premutation carriers. Patients affected by FXTAS have elevated levels of ribo-rCGG repeat containing FMR1 mRNA with normal to slightly reduced levels of FMRP in blood leukocytes. Coupled with the absence of FXTAS in fragile X syndrome patients, this suggests premutation-sized elongated rCGG repeats in the FMR1 transcript rather than alterations in the levels of FMRP are responsible for the FXTAS pathology. Mice expressing rCGG in the context of Fmr1 or the enhanced green fluorescent protein specifically in Purkinje neurons were generated to segregate the effects of rCGG from alterations in Fmr1 and to provide evidence that rCGG is necessary and sufficient to cause pathology similar to human FXTAS. The models exhibit the presence of intranuclear inclusions in Purkinje neurons, Purkinje neuron cell death and behavioral deficits. These results demonstrate that rCGG expressed in Purkinje neurons outside the context of Fmr1 mRNA can result in neuronal pathology in a mammalian system and demonstrate that expanded CGG repeats in RNA are the likely cause of the neurodegeneration in FXTAS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19377084      PMCID: PMC2694692          DOI: 10.1093/hmg/ddp182

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  43 in total

1.  The CGG repeat and the FMR1 gene.

Authors:  Violeta Stoyanova; Ben A Oostra
Journal:  Methods Mol Biol       Date:  2004

2.  Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome.

Authors:  F Tassone; R J Hagerman; D Garcia-Arocena; E W Khandjian; C M Greco; P J Hagerman
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

3.  FMR1 premutation as a rare cause of late onset ataxia--evidence for FXTAS in female carriers.

Authors:  Ch Zühlke; A Budnik; U Gehlken; A Dalski; S Purmann; M Naumann; M Schmidt; K Bürk; E Schwinger
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

4.  Cognitive decline, neuromotor and behavioural disturbances in a mouse model for fragile-X-associated tremor/ataxia syndrome (FXTAS).

Authors:  Debby Van Dam; Vanessa Errijgers; R Frank Kooy; Rob Willemsen; Edwin Mientjes; Ben A Oostra; Peter Paul De Deyn
Journal:  Behav Brain Res       Date:  2005-07-30       Impact factor: 3.332

5.  Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivation.

Authors:  Elizabeth Berry-Kravis; Kristina Potanos; Dahlia Weinberg; Lili Zhou; Christopher G Goetz
Journal:  Ann Neurol       Date:  2005-01       Impact factor: 10.422

6.  Relative levels of the two mammalian Rad23 homologs determine composition and stability of the xeroderma pigmentosum group C protein complex.

Authors:  Yuki Okuda; Ryotaro Nishi; Jessica M Y Ng; Wim Vermeulen; Gijsbertus T J van der Horst; Toshio Mori; Jan H J Hoeijmakers; Fumio Hanaoka; Kaoru Sugasawa
Journal:  DNA Repair (Amst)       Date:  2004-10-05

7.  Aging in individuals with the FMR1 mutation.

Authors:  S Jacquemont; F Farzin; D Hall; M Leehey; F Tassone; L Gane; L Zhang; J Grigsby; T Jardini; F Lewin; E Berry-Kravis; P J Hagerman; R J Hagerman
Journal:  Am J Ment Retard       Date:  2004-03

8.  Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice.

Authors:  Tao Zu; Lisa A Duvick; Michael D Kaytor; Michael S Berlinger; Huda Y Zoghbi; H Brent Clark; Harry T Orr
Journal:  J Neurosci       Date:  2004-10-06       Impact factor: 6.167

9.  Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation.

Authors:  R J Hagerman; B R Leavitt; F Farzin; S Jacquemont; C M Greco; J A Brunberg; F Tassone; D Hessl; S W Harris; L Zhang; T Jardini; L W Gane; J Ferranti; L Ruiz; M A Leehey; J Grigsby; P J Hagerman
Journal:  Am J Hum Genet       Date:  2004-04-02       Impact factor: 11.025

10.  Prevalence of carriers of premutation-size alleles of the FMRI gene--and implications for the population genetics of the fragile X syndrome.

Authors:  F Rousseau; P Rouillard; M L Morel; E W Khandjian; K Morgan
Journal:  Am J Hum Genet       Date:  1995-11       Impact factor: 11.025

View more
  65 in total

Review 1.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

Review 2.  RNA-binding proteins in microsatellite expansion disorders: mediators of RNA toxicity.

Authors:  Gloria V Echeverria; Thomas A Cooper
Journal:  Brain Res       Date:  2012-02-22       Impact factor: 3.252

Review 3.  Epigenetics in nucleotide repeat expansion disorders.

Authors:  Fang He; Peter K Todd
Journal:  Semin Neurol       Date:  2012-01-21       Impact factor: 3.420

Review 4.  Role of noncoding RNAs in trinucleotide repeat neurodegenerative disorders.

Authors:  Huiping Tan; Zihui Xu; Peng Jin
Journal:  Exp Neurol       Date:  2012-01-27       Impact factor: 5.330

5.  Mouse models of the fragile x premutation and the fragile X associated tremor/ataxia syndrome.

Authors:  Michael R Hunsaker; Gloria Arque; Robert F Berman; Rob Willemsen; Renate K Hukema
Journal:  Results Probl Cell Differ       Date:  2012

Review 6.  New pathologic mechanisms in nucleotide repeat expansion disorders.

Authors:  C M Rodriguez; P K Todd
Journal:  Neurobiol Dis       Date:  2019-06-21       Impact factor: 5.996

Review 7.  Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanisms.

Authors:  Paul Hagerman
Journal:  Acta Neuropathol       Date:  2013-06-21       Impact factor: 17.088

Review 8.  What has been learned from mouse models of the Fragile X Premutation and Fragile X-associated tremor/ataxia syndrome?

Authors:  Molly M Foote; Milo Careaga; Robert F Berman
Journal:  Clin Neuropsychol       Date:  2016-06-29       Impact factor: 3.535

Review 9.  FMR1: a gene with three faces.

Authors:  Ben A Oostra; Rob Willemsen
Journal:  Biochim Biophys Acta       Date:  2009-02-21

10.  CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size.

Authors:  Anna Lisa Ludwig; Glenda M Espinal; Dalyir I Pretto; Amanda L Jamal; Gloria Arque; Flora Tassone; Robert F Berman; Paul J Hagerman
Journal:  Hum Mol Genet       Date:  2014-01-23       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.